Nominations Due May 30 for CDC/HRSA Advisory Committee

Nominations Due May 30 for CDC/HRSA Advisory Committee

Thursday, April 5, 2018

HRSA is seeking nominations to the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC) (see below: Purpose of the CHAC). Four slots are open for candidates who have expertise in one or more of these areas: public health; epidemiology; laboratory practice; immunology; infectious diseases; behavioral health and science including, but not limited to opioid use and related expertise; health education; health care delivery; state health programs; clinical care; preventive health; medical education; health services and clinical research; and health care financing. In addition, people living with HIV and affected populations as well as individuals employed by state and local health and education agencies, HIV/viral hepatitis/STD community-based organizations, and the ethics or religious community are encouraged to submit nomination packages for consideration. Members serve up to 4-year terms on the CHAC.  

How to Submit a Nomination

No later than May 30, 2018, interested parties may send an email to [email protected] and include:

  1. a statement clearly indicating the name and affiliation of the nominee, the basis for the nomination (e.g., specific attributes such as experience, education, current affiliations, positions), and confirmation that the nominee is willing to serve as a member of the Committee
  2. the nominee’s name, address, daytime telephone number, and email address; and
  3. a current copy of the nominee’s curriculum vitae.

Nomination packages may be summited directly by the individual being nominated or by the person/organization recommending the candidate.

For More Information

See the CHAC Advisory Committee Website for additional information about the CHAC or contact CDR Holly Berilla, HRSA, HIV/AIDS Bureau, at [email protected] or by telephone at 301-443-9965. 

CHAC Purpose

The purpose of the CHAC, according to its charter, is to advise the Secretary, HHS; the Director, CDC; and the Administrator, HRSA regarding objectives, strategies, policies, and priorities for HIV, viral hepatitis, and other STDs; prevention and treatment efforts including surveillance of HIV infection, viral hepatitis, and other STDs, and related behaviors; epidemiologic, behavioral, health services, and laboratory research on HIV/AIDS, viral hepatitis, and other STDs; identification of policy issues related to HIV/viral hepatitis/STD professional education, patient healthcare delivery, and  prevention services; Agency policies about prevention of HIV/AIDS, viral hepatitis and other STDs; treatment, healthcare delivery, and research and training; strategic issues influencing the ability of CDC and HRSA to fulfill their missions of providing prevention and treatment services; programmatic efforts to prevent and treat HIV, viral hepatitis, and other STDs; and support to the Agencies in their development of responses to emerging health needs related to HIV, viral hepatitis, and other STDs.